USFDA Flags 4 Procedural Observations at Piramal Pharma’s Telangana Plant
The US Food and Drug Administration (USFDA) has issued a Form 483 with four observations to Piramal Pharma following an inspection of its Digwal manufacturing facility in Telangana.The inspection was conducted between February 9 and February 13, 2026, at the company’s plant located in Telangana. At the conclusion of the review, the US regulator issued…
